Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Activin A more prominently regulates muscle mass in primates than does GDF8
Esther Latres, Jason Mastaitis, Wen Fury, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 153

Showing 1-25 of 153 citing articles:

Activin A in Mammalian Physiology
Enrrico Bloise, Pasquapina Ciarmela, Cynthia Dela Cruz, et al.
Physiological Reviews (2018) Vol. 99, Iss. 1, pp. 739-780
Open Access | Times Cited: 167
ACTRIIA-Fc rebalances activin/GDF versus BMP signaling in pulmonary hypertension
Lai‐Ming Yung, Peiran Yang, Sachindra R. Joshi, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 543
Open Access | Times Cited: 162
Sarcopenia, osteoporosis and frailty
Evelien Gielen, Jolan Dupont, Marian Dejaeger, et al.
Metabolism (2023) Vol. 145, pp. 155638-155638
Closed Access | Times Cited: 104
Antibody blockade of activin type II receptors preserves skeletal muscle mass and enhances fat loss during GLP-1 receptor agonism
Elizabeth de Fougerolles Nunn, Natasha Jaiswal, Matthew Gavin, et al.
Molecular Metabolism (2024) Vol. 80, pp. 101880-101880
Open Access | Times Cited: 30
Muscle-derived myostatin is a major endocrine driver of follicle-stimulating hormone synthesis
Luisina Ongaro, Xiang Zhou, Ying Wáng, et al.
Science (2025) Vol. 387, Iss. 6731, pp. 329-336
Closed Access | Times Cited: 5
Themyostatingene: an overview of mechanisms of action and its relevance to livestock animals
Domenico Aiello, Ketan Patel, Emiliano Lasagna
Animal Genetics (2018) Vol. 49, Iss. 6, pp. 505-519
Open Access | Times Cited: 135
Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches
Virginie Mariot, Romain Joubert, Christophe Hourdé, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 124
Mitochondria as a Target for Mitigating Sarcopenia
Paul M. Coen, Robert V. Musci, J. Matthew Hinkley, et al.
Frontiers in Physiology (2019) Vol. 9
Open Access | Times Cited: 124
Osteogenesis Imperfecta: New Perspectives From Clinical and Translational Research
Josephine T. Tauer, Marie‐Eve Robinson, Frank Rauch
JBMR Plus (2019) Vol. 3, Iss. 8
Open Access | Times Cited: 120
Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy
Frédéric Morvan, Jean‐Michel Rondeau, Chaochun Zou, et al.
Proceedings of the National Academy of Sciences (2017) Vol. 114, Iss. 47, pp. 12448-12453
Open Access | Times Cited: 115
Pathophysiological mechanisms leading to muscle loss in chronic kidney disease
Xiaonan H. Wang, William E. Mitch, S. Russ Price
Nature Reviews Nephrology (2021) Vol. 18, Iss. 3, pp. 138-152
Closed Access | Times Cited: 102
Targeting the myostatin signaling pathway to treat muscle loss and metabolic dysfunction
Se‐Jin Lee
Journal of Clinical Investigation (2021) Vol. 131, Iss. 9
Open Access | Times Cited: 97
Targeting myostatin/activin A protects against skeletal muscle and bone loss during spaceflight
Se‐Jin Lee, Adam Lehar, Jessica U. Meir, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 38, pp. 23942-23951
Open Access | Times Cited: 96
The clinical impact and biological mechanisms of skeletal muscle aging
Zaira Aversa, Xu Zhang, Roger A. Fielding, et al.
Bone (2019) Vol. 127, pp. 26-36
Open Access | Times Cited: 80
Effects of 16 Weeks of Resistance Training on Muscle Quality and Muscle Growth Factors in Older Adult Women with Sarcopenia: A Randomized Controlled Trial
Myong-Won Seo, Sung-Woo Jung, Sung-Woo Kim, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 13, pp. 6762-6762
Open Access | Times Cited: 77
Myostatin and its Regulation: A Comprehensive Review of Myostatin Inhibiting Strategies
Mohammad Hassan Baig, Khurshid Ahmad, Jun Sung Moon, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 64
Out of Control: The Role of the Ubiquitin Proteasome System in Skeletal Muscle during Inflammation
Stefanie Haberecht-Müller, Elke Krüger, Jens Fielitz
Biomolecules (2021) Vol. 11, Iss. 9, pp. 1327-1327
Open Access | Times Cited: 61
Inhibition of myostatin and related signaling pathways for the treatment of muscle atrophy in motor neuron diseases
Elena Abati, Arianna Manini, Giacomo P. Comi, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 7
Open Access | Times Cited: 47
Myostatin: A Skeletal Muscle Chalone
Se‐Jin Lee
Annual Review of Physiology (2022) Vol. 85, Iss. 1, pp. 269-291
Open Access | Times Cited: 47
Associations between biomarkers of cellular senescence and physical function in humans: observations from the lifestyle interventions for elders (LIFE) study
Roger A. Fielding, Elizabeth J. Atkinson, Zaira Aversa, et al.
GeroScience (2022) Vol. 44, Iss. 6, pp. 2757-2770
Open Access | Times Cited: 45
The impact of weight loss on fat-free mass, muscle, bone and hematopoiesis health: Implications for emerging pharmacotherapies aiming at fat reduction and lean mass preservation
Konstantinos Stefanakis, Michail Kokkorakis, Christos S. Mantzoros
Metabolism (2024), pp. 156057-156057
Closed Access | Times Cited: 17
Advances in sarcopenia: mechanisms, therapeutic targets, and intervention strategies
Youle Zheng, Feng Jin, Yixin Yu, et al.
Archives of Pharmacal Research (2024) Vol. 47, Iss. 4, pp. 301-324
Closed Access | Times Cited: 13
GDF8 and activin A are the key negative regulators of muscle mass in postmenopausal females: a randomized phase I trial
Dinko González Trotter, Stephen Donahue, Chris Wynne, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
GDF8 and activin A blockade protects against GLP-1–induced muscle loss while enhancing fat loss in obese male mice and non-human primates
Jason Mastaitis, Daniel R. Gomez, José G. Raya, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Supraphysiologic Administration of GDF11 Induces Cachexia in Part by Upregulating GDF15
Juli E. Jones, Samuel M. Cadena, Chenguang Gong, et al.
Cell Reports (2018) Vol. 22, Iss. 6, pp. 1522-1530
Open Access | Times Cited: 76
Page 1 - Next Page

Scroll to top